UroGen Pharma Ltd is a globally recognised pharmaceutical firm that has a strong presence in markets worldwide and is dedicated to delivering groundbreaking therapeutic solutions to improve patient care.
Operating in the rapidly evolving pharmaceutical industry, Urogen Pharma Ltd provides specialised solutions in the urology sector. The company concentrates its efforts on creating treatments for uro-oncological diseases that lack effective solutions. UroGen is best known for its chemotherapy product Jelmyto.
Monitor the URGN share price by adding it to your eToro watchlist.